Does Cancer Treatment Impact COVID19 Vaccine’s Effectiveness?

  • QMA_PublicRelations
  • News
Many people are adequately protected from COVID19 with the multiple effective vaccines.  However, immunocompromised patients with cancer on active therapy may not develop immunity to COVID19. For those patients, long acting antibody (Evusheld) is now available to protect against COVID19. Evusheld may reduce the risk of infection by 77% especially in people with other complicating
Keep Reading
  • MARCH 17, 2022
  • Comments: 0